Evidence map›Paper›PMID 38270297›Full record

ArticleImmunity, inflammation and disease2024

A community based seroprevalence of SARS-CoV-2 antibodies in Somali Region, Eastern Ethiopia.

Solomon Yared, Tsegalem Abera, Seid Mohammed Ali, Abdifatah Muktar Muhummed, Mohammed Ibrahim, Abdulahi Hussen, Jan Hattendorf, Jakob Zinsstag, Rea Tschopp

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Immunity, inflammation and disease, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Solomon YaredDepartment of Biology, College of Natural and Computational Sciences, Jigjiga University, Jigjiga, Ethiopia.
Tsegalem AberaDepartment of Veterinary Microbiology and Public Health, College of Veterinary Medicine, Jigjiga University, Jigjiga, Ethiopia.ORCID 0000-0003-4454-1581
Seid Mohammed AliDepartment of Animal and Range Sciences, College of Dryland Agriculture, Jigjiga University, Jigjiga, Ethiopia.
Abdifatah Muktar MuhummedDepartment of Epidemiology and Public Health, Swiss Tropical and Public Health Institute, University of Basel, Basel, Switzerland.
Mohammed IbrahimDepartment of Veterinary Microbiology and Public Health, College of Veterinary Medicine, Jigjiga University, Jigjiga, Ethiopia.
Abdulahi HussenSchool of Medicine, College of Medicine and Health Sciences, Jigjiga University, Jigjiga, Ethiopia.
Jan HattendorfDepartment of Epidemiology and Public Health, Swiss Tropical and Public Health Institute, University of Basel, Basel, Switzerland.
Jakob ZinsstagDepartment of Epidemiology and Public Health, Swiss Tropical and Public Health Institute, University of Basel, Basel, Switzerland.
Rea TschoppDepartment of Epidemiology and Public Health, Swiss Tropical and Public Health Institute, University of Basel, Basel, Switzerland.

Funding

Swiss Development and Cooperation Agency (SDC) 7F-09057.01.02
6 · The paper itself

Abstract

backgroundCoronavirus disease 19 (COVID-19) is life-threatening infectious disease caused by SARS-CoV-2 virus that caused a global pandemic. SARS-CoV-2 has been widely transmitted throughout Ethiopia, with over 501,060 cases confirmed and 7574 deaths until November 2023. This study assessed for the first time the seroprevalence SARS-CoV-2 in the general population of the Somali Region during the COVID-19 pandemic.

methodsA cross-sectional study design was conducted from May to June 2021 in 14 districts of Somali Region. Blood samples were collected in 820 participants in addition to administering a questionnaire that included sociodemographic characteristics and history of clinical symptoms of COVID-19. Blood samples were tested for the presence or absence of anti-SARS-CoV-2 using a commercial Enzyme-Linked Immunosorbent Assay (ELISA) kit (Euroimmun).

resultsOverall, 477 (58.2%) were male and 343 (41.8%) were female. The majority of the participants (N = 581; 70.9%) were between 18 and 34 years old and not vaccinated against COVID-19 (N = 793; 96.7%). The overall seroprevalence of SARS-CoV-2 antibodies was 41.7% (95% CI: 33.3%-47.6%). The highest prevalence was found in Goljano district (70%) and the lowest in Gunagado district (22.5%). Only age was found to be associated with COVID-19 seropositivity.

conclusionPrevalence of SARS-CoV-2 antibodies was the highest ever reported in Ethiopia, indicating that a large proportion of the population had been infected 14 months after the start of the outbreak in the country. Such studies are important to swiftly reassess and improve specific COVID-19 preventive and control measures to reduce transmissions within the community in a given setting.

Indexed as

COVID-19AdolescentAdultAntibodies, ViralCross-Sectional StudiesEthiopiaFemaleHumansMalePandemicsSARS-CoV-2Seroepidemiologic StudiesSomaliaYoung AdultAntibodies, ViralcommunitySARS-CoV-2seroprevalenceSomali Region

Identifiers

PMID38270297
PMCPMC10777752

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.